Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer (Q36883381)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2007
edit
Language Label Description Also known as
English
Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer
scientific article published on July 2007

    Statements

    Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit